A systematic review of the sensitivity and specificity of lateral flow devices in the detection of SARS-CoV-2

Mistry, Dylan A.; Wang, Jenny Y.; Moeser, Mika-Erik; Starkey, Thomas; Lee, Lennard Y. W.

doi:10.1186/s12879-021-06528-3

BMC Infectious Diseases

Table 1 Data describing study design, population and setting

From: A systematic review of the sensitivity and specificity of lateral flow devices in the detection of SARS-CoV-2

Study	Month and year of publication	Origin	Sample size	Gender = Female	Gender = Male	Mean Age	Population	Setting—Dichotomise	Sample collection (who collected it and when)	Intervention (which LFD)
Abdelrazik et al. [12]	December 2020	Egypt	310	126	184	42.0	Confirmed, contacts and exposed healthcare professionals	Primary Healthcare Facility/Hospital	N/A	BIOCREDIT
Abdulrahman et al. [13]	December 2020	Bahrain	4183	1820	2363	30.9	Mildly symptomatic	COVID-19 Testing Site	Trained healthcare professionals	Panbio
Albert et al. [14]	November 2020	Spain	412	239	173	31.0	Symptomatic	Primary Healthcare Facility/Hospital	Trained healthcare professionals	Panbio
Berger et al. [15]	November 2020	Geneva, Switzerland	529	285	244	34.9	Symptoms/contact	COVID-19 Testing Site	Trained healthcare professionals	Panbio; STANDARD Q
Blairon et al. [16]	August 2020	Belgium	774	N/A	N/A	N/A	N/A	Primary Healthcare Facility/Hospital	N/A	Coris
Bulilete et al. [17]	November 2020	Mallorca, Spain	1369	743	626	42.5	Symptoms/contact	COVID-19 Testing Site	Trained healthcare professionals	Panbio
Cerutti et al. [18]	September 2020	Italy	330	134	196	44.6	Symptomatic/high-risk travel	N/A	N/A	STANDARD Q
Chaimayo et al. [19]	November 2020	Thailand	454	231	223	40.4	Symptomatic	Primary Healthcare Facility/Hospital	N/A	STANDARD Q
Courtellemont et al. [20]	October 2020	France	248	131	117	43.0	Asymptomatic and symptomatic	Primary Healthcare Facility/Hospital	Trained personnel	COVID-VIRO
Drevinek et al. [21]	November 2020	Czech Republic	591	327	246	40.0	Symptoms/contact	Primary Healthcare Facility/Hospital	N.A	Panbio; STANDARD Q
Gremmels et al. [22]	October 2020	Netherlands	1575	844	523	36.4	Symptomatic	Primary Healthcare Facility/Hospital	N/A	Panbio
Iglὁi et al. [23]	November 2020	Rotterdam, Netherlands	970	776	194	53.0	Symptomatic	COVID-19 Testing Site	Trained personnel	STANDARD Q
L.J. Krüger et al. (2020) [24]	December 2020	Heidelberg and Berlin, Germany	1108	78	1030	39.4	Symptoms/contact	COVID-19 Testing Site	Trained personnel	Panbio
L.J. Krüger et al. (2020) [25]	October 2020	Berlin and Heidelberg, Germany. Liverpool, UK	2417	1276	1140	40.4	Symptoms/contact	Both	N/A	Bioeasy, Coris, STANDARD Q
Linares et al. [26]	October 2020	Madrid, Spain	255	148	107	46.4	Symptoms/contact (ER), both asymptomatic and symptomatic (72.1%) in PH	Primary Healthcare Facility/Hospital	N/A	Panbio
Masiá et al. [27]	November 2020	Alicante, Spain	913	490	423	40.6	Symptoms/contact	Primary Healthcare Facility/Hospital	Trained healthcare professionals	Panbio
Merino-Amador et al. [28]	November 2020	Madrid and Basque Country, Spain	958	587	370	42.4	Symptoms/contact	Primary Healthcare Facility/Hospital	Trained healthcare professionals	Panbio
Moeren et al. [29]	October 2020	Netherlands	352	N/A	N/A	N/A	Symptomatic	COVID-19 Testing Site	Trained personnel	BD Veritor
Nalumansi et al. [30]	October 2020	Uganda	262	29	233	34.0	N/A	Primary Healthcare Facility/Hospital	Laboratory personnel	STANDARD Q
Peto et al. [31]	January 2021	Multiple sites across the UK	6954	N/A	N/A	N/A	RT-PCR-confirmed diagnosis of SARS-CoV-2 infection within 5 days of the original PCR result	Both	Self-test	Innova
Porte et al. [32]	October 2020	Santiago, Chile	127	59	68	38.0	Symptoms/contact	Primary Healthcare Facility/Hospital	Trained personnel	Bioeasy
Schwob et al. [33]	November 2020	Lausanne, Switzerland	928	455	473	31.0	symptomatic	COVID-19 Testing Site	NP = health professional, saliva = self	STANDARD Q; Panbio; COVID-VIRO
Torres et al. [34]	December 2020	Spain	634	355	279	37.0	Asymptomatic contacts	Primary Healthcare Facility/Hospital	Trained healthcare professionals	Panbio
Veyrenche et al. [35]	September 2020	Montpellier, France	65	N/A	N/A	N/A	Asymptomatic and symptomatic	Primary Healthcare Facility/Hospital	N/A	Coris

Back to article page

ISSN: 1471-2334

Contact us

Submission enquiries: bmcinfectiousdiseases@biomedcentral.com
General enquiries: ORSupport@springernature.com